Outcomes in Older Patients with Newly Diagnosed High-Risk/Secondary AML (sAML) who Achieve Remission with CPX-351 versus 7+3 InductionS. Faderl,G. L. Uy, G. J. Schiller, J. E. Cortes, E. K. Ritchie, R. J. Ryan,M. Chiarella, A. C. LouieANNALS OF HEMATOLOGY（2019）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
